Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Abnormal catecholamine mechanisms in hypothalamic-pituitary disorders

G R Van Loon

    Metabolism: Clinical and Experimental
    |November 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Viral pericarditis: a report of five cases.

    Canadian Medical Association journal·2010
    Same author

    Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats.

    Neuropeptides·1996
    Same author

    Effects of beta-FNA on sympathoadrenal, cardiovascular, and analgesic responses to DAMPGO at rest and during stress.

    Pharmacology, biochemistry, and behavior·1996
    Same author

    Effects of nicotine on the concentration of native and cryptic Met- and Leu-enkephalin in peripheral tissues.

    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·1994
    Same author

    Plasma Met-enkephalin and catecholamine responses to intense exercise in humans.

    Journal of applied physiology (Bethesda, Md. : 1985)·1992
    Same author

    Effect of diabetes on the levels of two forms of Met-enkephalin in plasma and peripheral tissues of the rat.

    Neuropeptides·1992
    Same journal

    Ablation of microglial estrogen receptor alpha predisposes male mice to diet-induced obesity.

    Metabolism: clinical and experimental·2026
    Same journal

    Pathophysiology-based subtypes of individuals at high risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes.

    Metabolism: clinical and experimental·2026
    Same journal

    A thermosensitive TET-Parkin epigenetic axis couples mitochondrial quality control to adaptive thermogenesis in adipose tissue.

    Metabolism: clinical and experimental·2026
    Same journal

    Raffinose targets the NQO1/NF-κB axis to attenuate DON-driven microglial activation and neuroinflammation via metabolic reprogramming.

    Metabolism: clinical and experimental·2026
    Same journal

    Endothelial NPR-C promotes insulin resistance via Caveolin-1-mediated insulin transcytosis.

    Metabolism: clinical and experimental·2026
    Same journal

    Macrophage-enriched GPR91 aggravates acute liver injury by inhibiting efferocytosis via the AC/cAMP/PPARγ pathway.

    Metabolism: clinical and experimental·2026
    See all related articles

    Patients with pituitary tumors and anorexia nervosa exhibit abnormal plasma catecholamine levels, suggesting disordered catecholamine metabolism in these neuroendocrine conditions.

    Area of Science:

    • Neuroendocrinology
    • Biochemistry

    Background:

    • Pituitary tumors, specifically those secreting growth hormone or prolactin, can disrupt hormonal balance.
    • Anorexia nervosa is a complex eating disorder with known metabolic and hormonal disturbances.

    Purpose of the Study:

    • To investigate plasma catecholamine responses in patients with specific pituitary tumors and anorexia nervosa.
    • To explore potential links between neuroendocrine disorders and catecholamine metabolism.

    Main Methods:

    • Assessed plasma catecholamine concentrations (dopamine, norepinephrine, epinephrine) in patient cohorts.
    • Administered oral bromocriptine to patients with pituitary tumors and monitored catecholamine responses.

    Main Results:

    • Patients with growth hormone or prolactin-secreting pituitary tumors showed blunted plasma catecholamine responses to bromocriptine.

    Related Experiment Videos

  • These patients maintained normal basal plasma catecholamine levels.
  • Patients with anorexia nervosa presented with low basal levels of dopamine, norepinephrine, and epinephrine.

    • Conclusions:

    • Disordered catecholamine metabolism is indicated in patients with growth hormone/prolactin-secreting pituitary tumors and anorexia nervosa.
    • Catecholamine dysregulation may be a shared feature of these distinct neuroendocrine disorders.